Cited by 5Alzheimer's disease research and treatmentsPrion Diseases and Protein MisfoldingDementia and Cognitive Impairment Research

Spontaneous pathology in PS19 tauopathy mice progresses via brain networks

Open access
Ramirez, Denise M.O., Whitesell, Jennifer D., Bhagwat, Nikhil, Thomas, Talitha L., Ajay, Apoorva D., Nawaby, Ariana, Delatour, Benoît, Bay, Sylvie +4 more·2025·Neurobiology of Disease

Abstract

Tauopathies are progressive neurodegenerative diseases characterized by cellular accumulation of the microtubule-associated protein tau. Evidence suggests tau is a prion, propagating pathology across brain networks via unique transmissible assemblies which mediate distinct neuropathologies in model systems. Neuroimaging has identified network alterations reflecting distinct patterns of brain atrophy in tauopathy patients. Preclinical studies confirmed transmission of pathological tau between connected brain areas, but relied on inoculation of pathogenic tau protein, leaving a gap in experimental evidence that spontaneous tau aggregates act as prions. We used anti-phospho-tau nanobodies in combination with serial two-photon tomography to immunostain and image whole brains from male and female PS19 mice, which have pan-neuronal expression of full-length human tau containing the P301S mutation. We analyzed patterns of phospho-tau deposition across established brain networks at multiple ages, testing the relationship between structural connectivity and patterns of progressive pathology. We identified core regions with early phospho-tau deposition, and used network propagation modeling to determine the link between tau pathology and connectivity strength. We found that tauopathy progression correlated with structural connectivity, consistent with the prion model. Spontaneous tau propagation was biased in the retrograde direction. These data suggest that despite widespread pathological human tau expression in PS19 mice, spontaneous phospho-tau pathology initiates and propagates along specific brain networks. This work establishes new preclinical methods for studying tau accumulation and propagation, and fills a major gap in our understanding of spontaneous tauopathy. Our novel approach establishes a fundamental role for brain networks in tau propagation, with implications for human disease. Significance statement Our novel methodology for whole brain imaging of p-tau deposition reveals retrograde-dominant network propagation in a tauopathy mouse model. This work establishes new preclinical methods for studying tau accumulation and propagation, and fills a major gap in our understanding of spontaneous tauopathy. Our results establish a fundamental role for brain networks in tau propagation, with implications for human disease.

AI snapshot

Written from the paper’s full text.

TL;DR

Using an anti-phospho-tau nanobody with serial two-photon tomography, this study mapped spontaneous tau pathology across whole PS19 mouse brains and found that p-tau deposition initiates in discrete regions and progresses along structural brain networks. Network diffusion modeling showed that progression is best predicted by retrograde connectivity, supporting prion-like network propagation of endogenous tau pathology.

Key findings

  • Spontaneous p-tau pathology was nonrandom: cluster analysis across 23 brains and 315 Allen CCFv3 regions revealed distinct subcortical and cortical late-stage patterns, with no obvious hemispheric asymmetry (Pearson’s r = 0.9226, p < 1e-12).
  • p-tau-positive regions were more strongly interconnected than expected by chance (z-scores > 2), and seven consistent seed regions were identified at 6 months: AHN, PA, PGRNl, B, LC, ENTm, and MV.
  • The retrograde connectivity model best predicted later p-tau levels; excluding three “cortical” pattern brains improved retrograde model Pearson’s r from 0.61 to 0.66 at 10 months and from 0.45 to 0.66 at 12 months.
  • The retrograde model significantly outperformed single- and multiple-random-seed null models (p < 0.01 at all ages) and rewired-network null models at 10–11 months with cortical brains included and at 10–12 months with them excluded (p < 0.05).

Methods

  • PS19 mice expressing 4R1N P301S human tau under the murine prion promoter were analyzed at 3 (n = 5), 6 (n = 5), 9 (n = 3), 10 (n = 6), 11 (n = 5), and 12 (n = 4) months; TauKO controls were also used, and both sexes were included except the 6-month PS19 group, which was all female.
  • Brains were immunostained with fluorescent VHH-A2-488 nanobody against pS422 tau, imaged by serial two-photon tomography, processed with supervised machine-learning pixel classification, registered to the Allen CCFv3 atlas, and quantified per annotated brain region with background subtraction.
  • Regional distribution analysis compared connectivity strength among p-tau-positive regions to distance-matched random networks; network diffusion models on the directed Allen connectome used seven seed regions and compared Euclidean, anterograde, retrograde, and bidirectional spread, with permutation-based null models.

Limitations

  • Stated: the study was not powered to assess sex differences as a primary outcome, and the 6-month PS19 group was all female; p-tau burden varied across animals, and transgene expression variation across brain regions could affect regional deposition, though no regional differences in transgene expression were observed.
  • Stated: the analysis used a wild-type mouse connectivity map, and tau expression could in principle alter network connectivity, though no altered connections have been reported; too few intermediate-stage mice were available to distinguish cortical vs. subcortical progression paths.
  • Evident: sample sizes were small per age (n = 3–6), the design was cross-sectional rather than longitudinal, five brains were excluded during quality control, and background subtraction relied on thresholding that could affect false-positive and false-negative assignments.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2025.107072

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

27 of 39 cited sources checked · 12 supported · 1 flagged · accuracy not yet measured

  • Premisecitation

    Consistent levels of human tau expression across the lifespan of PS19 mice have been reported in plasma, whole brain, and brain subregions including brainstem and hippocampus.

    “Consistent levels of human tau expression across the lifespan of PS19 mice have also been reported in plasma, whole brain (Sun et al., 2020), and brain subregions including brainstem and hippocampus (Ono et al., 2022).”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites Sun et al., 2020 source

      The Sun et al. citation is attached to plasma and whole-brain levels, not the brain-subregion claim cited to Ono et al. In Results, the paper reports that plasma human tau tended to increase from 3 to 8 months and stabilized only after 9 months; it also says human tau in total brain kept increasing from 3 to 12 months. Those findings contradict consistent levels across the observed ages. (LLM, conf=0.91)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
    • cites Ono et al., 2022 source

      The Results (Figure 1f,h; page not specified) report similar human P301S tau expression levels in the hippocampus and brainstem of PS19 mice. Figure 1 describes samples at 4 and 10 months, but the text does not establish consistent expression across the lifespan. The plasma and whole-brain claims are not attributed to Ono et al. in the citing sentence. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Premisecitation

    In humans, MRI-based studies using fMRI and tractography cannot precisely map pathology at the cellular level.

    “In humans, magnetic resonance imaging- (MRI) based studies using functional MRI (fMRI) and tractography cannot precisely map pathology at the cellular level.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Seeley et al., 2009 source

      The Experimental Procedures (Image acquisition and Image preprocessing and analysis; page unavailable) describe millimeter-scale MRI and fMRI measurements, while the Subjects section distinguishes imaging-defined clinical syndromes from underlying histopathology and says predicting neuropathology was not a goal. This supports a limitation on what this study’s imaging maps establish, but the paper does not state the general claim about cellular-level precision or address tractography’s ability to map pathology. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
  • Findingcitation

    The general pattern of p-tau accumulation in PS19 mice matched recent reports of brain-wide p-tau accumulation in the P301L tauopathy model.

    “The general pattern of p-tau accumulation matched recent reports of brain-wide p-tau accumulation in the P301L tauopathy model (Ramsden et al., 2005; Detrez et al., 2019).”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites Ramsden et al., 2005 source

      The ‘Pathological tau conformation and phosphorylation’ section reports age-dependent accumulation of phosphorylated tau in the cortex and hippocampus of rTg(tauP301L)4510 mice. Figure 1 and the Discussion describe expression as forebrain-restricted, so the paper supports accumulation across those regions but not the claim of brain-wide accumulation. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites Detrez et al., 2019 source
  • Premisecitation

    The pattern of resistance is consistent with a report of widely variable ages of induction of tau pathology in the PS19 model.

    “This pattern is also consistent with a report of widely variable ages of induction of tau pathology in the PS19 model (Woerman et al., 2017).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Woerman et al., 2017 source
  • Findingown data

    Human tau expression was consistently present across brain sections spanning the rostrocaudal extent of the hippocampus at 3, 6, 9 and 12 months of age in PS19 mice.

    “Staining for human tau (with HJ8.5 antibody (Yanamandra et al., 2013, Holmes et al., 2014)) showed consistent expression of human tau across brain sections spanning the rostrocaudal extent of the hippocampus at 3, 6, 9 and 12 months of age (Fig. 3).”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites Yanamandra et al., 2013 source
    • cites Holmes et al., 2014 source
  • Classified as probably not a substantial claim. 19
  • May combine two claims. 23
  • The quote only partly states this claim. 1
  • Classified as probably not a substantial claim.

    Premisecitation

    Tau propagates pathology among neurons.

    “Several lines of evidence indicate tau propagates pathology among neurons.”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites Frost et al., 2009 source

      The Abstract reports Tau-induced misfolding and transfer of aggregated Tau between co-cultured cells. The Discussion says these findings are consistent with propagation among neurons, but explicitly says that this idea awaits testing in vivo. The paper therefore supports evidence for a possible mechanism, not a demonstrated spread of pathology among neurons. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites Holmes et al., 2014 source
    • cites Clavaguera et al., 2009 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Advances in image registration and analysis of serial sections improve capacity for complete unbiased assessment.

    “Advances in image registration and analysis of serial sections improve this capacity (Furth et al., 2018; Cornblath et al., 2021), but remain laborious and limited to a subset of anatomical levels.”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites Furth et al., 2018 source
    • cites Cornblath et al., 2021 source

      The Results section, “Quantitative immunohistochemistry to evaluate pathological tau spread” (page unavailable), describes quantifying two sets of nearby sections to reduce selection bias. The Materials and Methods section, “Quantitative pathology” (page unavailable), describes digital analysis but also says annotations were modified by hand on sections selected at six anatomical levels. These passages support improved regional assessment through section analysis, but not an advance in image registration or a complete, unbiased assessment. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Tau forms strains, defined assembly conformations that propagate faithfully in vivo, creating unique transmissible pathologies.

    “Tau also forms strains, which are defined assembly conformations that propagate faithfully in vivo, creating unique transmissible pathologies (Sanders et al., 2014; Kaufman et al., 2016).”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites Sanders et al., 2014 source
    • cites Kaufman et al., 2016 source
  • Classified as probably not a substantial claim.

    Premisecitation

    Inoculation of mice with tauopathy homogenates produces local pathology that spreads beyond the injection site.

    “inoculation of mice with tauopathy homogenates produces local pathology that spreads beyond the injection site (Clavaguera et al., 2009).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Clavaguera et al., 2009 source

      The paper reports that brain extract from P301S tau mice induced pathology that spread beyond the injection site in transgenic mice expressing human wild-type tau. It also reports that pathology in non-transgenic mice remained confined to the injection site, so the claim needs that qualification. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Human MRI-based studies rely on atrophy patterns or low-resolution PET imaging of tau deposition, and histopathological analysis of end-stage disease.

    “Instead, they rely on atrophy patterns or relatively low-resolution positron emission tomography (PET) imaging of tau deposition, and histopathological analysis of end-stage disease (Seeley et al., 2009).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Seeley et al., 2009 source

      The Results and Experimental Procedures (page unavailable) describe MRI-derived atrophy patterns in patients with neurodegenerative syndromes, supporting that part of the claim. The paper does not describe low-resolution PET imaging of tau deposition or reliance on histopathological analysis of end-stage disease; it distinguishes its clinical syndromes from histopathological entities. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim.

    Premisecitation

    Human studies based on functional connectivity and tractography have suggested brain networks could play a role in tauopathy progression, consistent with the prion hypothesis.

    “Human studies based on functional connectivity and tractography have suggested brain networks could play a role in tauopathy progression, consistent with the prion hypothesis (Braak and Braak, 1991; Seeley et al., 2009; Drzezga, 2018; Frontzkowski et al., 2022).”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites Braak and Braak, 1991 source
    • cites Seeley et al., 2009 source

      The Discussion reports that dementia-related atrophy patterns align with functional brain networks and proposes prion-like, transsynaptic spread of misfolded proteins, including tau, as a possible mechanism. But this study examined clinical dementia syndromes rather than directly tracking tauopathy progression, and its described methods use functional connectivity and structural covariance, not tractography. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites Drzezga, 2018 source

      The main text (page not provided) reports human tau-imaging findings that overlap with functional brain networks and discusses possible prionlike spread of tau along those networks. It does not describe tractography-based human studies, so that methodological detail is unsupported by this source. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Prion protein inoculation propagates pathology in neuroanatomical networks.

    “Prion protein (PrP) inoculation also propagates pathology in neuroanatomical networks (Koshy et al., 2022).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Koshy et al., 2022 source
  • Classified as probably not a substantial claim.

    Premisecitation

    Tau assemblies enter cells to trigger intracellular aggregation.

    “Tau assemblies enter cells to trigger intracellular aggregation (Frost et al., 2009; Holmes et al., 2014)”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites Frost et al., 2009 source
    • cites Holmes et al., 2014 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Immunotherapies targeting extracellular tau reduce pathology in mice.

    “Finally, immunotherapies targeting extracellular tau reduce pathology in mice (Yanamandra et al., 2013).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Yanamandra et al., 2013 source
  • Classified as probably not a substantial claim.

    Premisecitation

    In humans, studies of the role of network involvement have combined functional connectivity or tractography with imaging of tau pathology based on positron emission tomography, or, as a surrogate, brain atrophy.

    “In humans, studies of the role of network involvement have combined functional connectivity or tractography, with imaging of tau pathology based on positron emission tomography, or, as a surrogate, brain atrophy (Seeley et al., 2009).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Seeley et al., 2009 source

      The Results section (‘Syndromic atrophy foci anchor large-scale functional networks in the healthy brain’; page unavailable) describes comparing syndromic brain-atrophy patterns with fMRI functional-connectivity maps. The cited study does not describe tractography or tau PET imaging. Its Discussion also cautions that the syndromes can arise from diverse molecular pathologies, so it does not establish atrophy as a surrogate specifically for tau pathology. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    In mouse models, network studies have been based on inoculation of seeds, which does not reflect a normal disease process, and is prone to experimental artifact.

    “In mouse models, network studies have been based on inoculation of seeds (Sanders et al., 2014; Detrez et al., 2019), which does not reflect a normal disease process, and is prone to experimental artifact.”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites Sanders et al., 2014 source

      The Results sections on tau pathology and spread in mice describe hippocampal inoculation followed by pathology in connected regions. The paper also says it cannot exclude spread of the inoculum itself as an explanation for the observed spread. It does not state that inoculation fails to reflect a normal disease process or that such studies are generally prone to experimental artifact. Page numbers were not available in our copy. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites Detrez et al., 2019 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The variability observed in p-tau burden across the lifespan is consistent with earlier reports showing significant variability in spontaneous hippocampal p-tau accumulation in aged male and female PS19 mice.

    “The variability which we observed in p-tau burden across the lifespan is consistent with earlier reports showing significant variability in spontaneous hippocampal p-tau accumulation in aged male and female PS19 mice (Sun et al., 2020; Woerman et al., 2017).”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites Sun et al., 2020 source

      The Results section (“Pathological tau development in P301S transgenic mice of different ages and sex”; page unavailable) reports age- and sex-related differences in hippocampal phosphorylated tau in P301S mice. It does not establish significant variability in spontaneous accumulation among aged mice within the male and female groups, as the citing sentence suggests. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
    • cites Woerman et al., 2017 source

      The Discussion (page not provided) reports substantial interanimal variability in AT8 staining in 31-week-old PS19 mice and in tau-prion content at 22–38 weeks. The study included males and females, but the cited passages do not establish variability specifically in spontaneous hippocampal p-tau accumulation in each sex; its tau-prion assay used half-brains rather than isolated hippocampi. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Findingown data

    Whole brain analysis of tau pathology defined characteristic, non-random patterns of p-tau deposition that progressed over time, with a bias towards retrograde propagation.

    “Whole brain analysis of tau pathology defined characteristic, non-random patterns of p-tau deposition that progressed over time, with a bias towards retrograde propagation.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Co-staining with HJ8.5 and VHH-A2-488 in PS19 brain sections at various ages indicated a consistent brain-wide pattern of human tau expression but restricted presentation of p-tau recognized by VHH-A2-488.

    “Further co-staining experiments with HJ8.5 and VHH-A2-488 in PS19 brain sections at various ages again indicated a consistent brain-wide pattern of human tau expression, but restricted presentation of p-tau recognized by the VHH-A2-488 (Fig. 4).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: VHH-A2-488 specifically recognizes p-tau in PS19 brain sections.
  • May combine two claims.

    Findingown data

    Per-structure background subtraction eliminated 488 false positives and resulted in 70 true positive structures falling below threshold and being assigned zero.

    “This per-structure background subtraction eliminated 488 false positives and resulted in 70 true positive structures falling below the threshold and being assigned a zero value (Supp. Fig. 4D).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The Euclidean distance-based model performed the worst at all ages, with the lowest Pearson's r.

    “The Euclidean distance-based model performed the worst at all ages, with the lowest Pearson’s r (Fig. 6C, gray, top row).”
    Quote in the paperSubstantial claim
  • The quote only partly states this claim.

    Findingown data

    Cluster analysis of region-normalized p-tau signals across 23 brains and 315 Allen CCFv3 brain regions revealed pathological patterns related to, but spanning, age groups.

    “This revealed pathological patterns related to, but spanning, age groups (Fig. 5A).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    At 9-10mos, p-tau signal increased in brainstem regions, and low-to-moderate signal appeared in more rostral regions, including hippocampus and isocortex.

    “At 9–10mos, p-tau signal increased in brainstem regions, and low-to-moderate signal appeared in more rostral regions, including hippocampus and isocortex (Fig. 1D, Fig. 2E–L, Supp. Fig. 2E–L, Supp. Fig. 3D–I).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    There were no obvious effects of sex on either pathological burden or presentation of the subcortical vs. cortical pattern of pathology.

    “With the caveat that our study was not powered to assess sex differences as a primary outcome, we found no obvious effects of sex on either pathological burden or presentation of the subcortical vs. cortical pattern of pathology (Table 1).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The predictive performance of the other three models also improved at 12mo when the three Cortical samples were excluded; however, the retrograde model still outperformed the other three models.

    “The predictive performance of the other three models also improved at 12mo when the three “Cortical” samples were excluded; however, the retrograde model still outperforms the other three models (Supp. Fig. 5).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    Independent populations of VHH-A2-488- and AT8-positive neurons were observed.

    “We also observed independent populations of VHH-A2-488- and AT8-positive neurons (data not shown)”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Positive correlations were observed between predicted and measured p-tau for all four models, but some outperformed others.

    “We observed positive correlations between predicted and measured p-tau for all four models, but some outperformed others.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingcitation

    Neurons stained with VHH-A2-488 were sometimes co-labeled with AT8 antibodies.

    “As observed previously (Li et al., 2016), neurons stained with VHH-A2-488 were sometimes co-labeled with AT8 antibodies (Fig. 1B).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Li et al., 2016

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Findingown data

    The bidirectional spread model predicted p-tau levels reasonably well and outperformed the anterograde model in every age group.

    “The bidirectional spread model (Fig. 6C, blue) predicted p-tau levels reasonably well and outperformed the anterograde model in every age group.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The emergence of additional sites of pathology was related to age, but not exclusively.

    “We determined that the emergence of additional sites of pathology was related to age, but not exclusively.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The retrograde model also significantly (p < 0.05) outperformed the "rewired" network null models at 10 and 11mo with inclusion of cortical brains, and in 10, 11, and 12mo age groups with the three cortical brains excluded.

    “The retrograde model also significantly (p < 0.05) outperformed the “rewired” network null models at 10 and 11mo with inclusion of cortical brains, and in 10, 11, and 12mo age groups with the three cortical brains excluded.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In three cases with dominant cortical pathology, selected seed regions did not effectively predict their involvement in later ages, reducing the apparent power of the network model.

    “In the three cases with dominant cortical pathology, selected seed regions did not effectively predict their involvement in later ages, reducing the apparent power of the network model.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Despite widespread pathological human tau expression in PS19 mice, spontaneous phospho-tau pathology initiates and propagates along specific brain networks.

    “These data suggest that despite widespread pathological human tau expression in PS19 mice, spontaneous phospho-tau pathology initiates and propagates along specific brain networks.”
    Quote in the paperSubstantial claim
    • The authors state this as an assumption: Network diffusion models assume linear diffusion of pathology over the brain connectome composed of white-matter tracts.
    • The authors state this as an assumption: Pathology spread from a given brain region to its neighbors is a function of their strength of connections and pathology differentials.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Neurodegenerative tauopathies are characterized by progressive neuronal and glial accumulation in amyloid assemblies of tau protein.

    “Neurodegenerative tauopathies are characterized by progressive neuronal and glial accumulation in amyloid assemblies of tau protein (Lee et al., 2001).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Lee et al., 2001 source
  • May combine two claims.

    Premisecitation

    Advances in image registration and analysis of serial sections remain laborious and limited to a subset of anatomical levels.

    “Advances in image registration and analysis of serial sections improve this capacity (Furth et al., 2018; Cornblath et al., 2021), but remain laborious and limited to a subset of anatomical levels.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Brain networks play a fundamental role in tau propagation, with implications for human disease.

    “Our novel approach establishes a fundamental role for brain networks in tau propagation, with implications for human disease.”
    Quote in the paperSubstantial claim
    • The authors state this as an assumption: Network diffusion models assume linear diffusion of pathology over the brain connectome composed of white-matter tracts.
    • The authors state this as an assumption: Pathology spread from a given brain region to its neighbors is a function of their strength of connections and pathology differentials.
  • May combine two claims.

    Premisecitation

    PS19 mice overexpress P301S mutant human tau and develop progressive accumulation of hyperphosphorylated and insoluble tau protein.

    “PS19 mice, which overexpress P301S mutant human tau and develop progressive accumulation of hyperphosphorylated and insoluble tau protein (Yoshiyama et al., 2007).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Yoshiyama et al., 2007 source
  • Probably not a substantial claim: may not pass S4 (based).

    Premisenone given

    The hypothesis of trans-neuronal propagation of endogenous tau pathology has remained fundamentally untested in vivo.

    “Consequently, the hypothesis of trans-neuronal propagation of endogenous tau pathology, while intriguing, has remained fundamentally untested in vivo.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The study was not powered to assess sex differences as a primary outcome.

    “With the caveat that our study was not powered to assess sex differences as a primary outcome, we found no obvious effects of sex on either pathological burden or presentation of the subcortical vs. cortical pattern of pathology (Table 1).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    The selected diffusion rate constant β remained well within predefined bounds for each fitted model, and model performance remained stable over small perturbations of β.

    “We checked that the selected β remained well within the predefined bounds for each fitted model, and the model performance remained stable over small perturbations of β.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    Background subtraction was performed to guard against potential interpretation errors from regional variability in probability value distribution.

    “Background subtraction was performed in order to guard against potential interpretation errors in the face of regional variability in the probability value distribution (i.e., to account for false positive probabilities caused by autofluorescence from lipofuscin or other sources).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given

    Brain-wide distribution patterns of p-tau significantly correlated with their network connection strength.

    “Overall, these analyses indicated that brain-wide distribution patterns of p-tau significantly correlated with their network connection strength.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    The simplest interpretation of the data is that pathology begins in discrete areas in PS19 mice, before propagating via network connections with a retrograde bias.

    “Thus, the simplest interpretation of our data is that pathology begins in discrete areas in PS19 mice, before propagating via network connections with a retrograde bias.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    The PS19, and perhaps other endogenous tauopathy models, remain useful for analysis of mechanisms of propagation, and development of diagnostic and therapeutic strategies that can be translated to humans.

    “It also indicates that the PS19, and perhaps other endogenous tauopathy models, remain useful for analysis of mechanisms of propagation, and development of diagnostic and therapeutic strategies that can be translated to humans.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Interpretationnone given

    Each of these human methods has poor cellular resolution, orders of magnitude below what was achieved here via STPT.

    “Each of these methods, while state-of-the-art in humans, has poor cellular resolution, orders of magnitude below what was achieved here via STPT.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Our observation that emergent cellular pathology in a mouse model with pan-neuronal mutant tau expression is accurately predicted by a retrograde propagation model suggests that in mice, as has been long hypothesized in humans, spontaneous tau prion phenomena underlie neuropathological progression.

    “However, our observation that emergent cellular pathology in a mouse model with pan-neuronal mutant tau expression is accurately predicted by a retrograde propagation model suggests that in mice, as has been long hypothesized in humans (Duyckaerts et al., 1997), spontaneous tau prion phenomena underlie neuropathological progression.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Duyckaerts et al., 1997 source
41 of 41
  • The authors state this as an assumption.

    Network diffusion models assume linear diffusion of pathology over the brain connectome composed of white-matter tracts.

    “These models hypothesize linear diffusion of pathology over the brain connectome composed of the white-matter tracts.”
  • The authors state this as an assumption.

    Pathology spread from a given brain region to its neighbors is a function of their strength of connections and pathology differentials.

    “Thus, the pathology spread from a given brain region to its neighbors is a function of their 1) strength of connections and 2) pathology differentials.”
  • The paper relies on this without support.

    VHH-A2-488 specifically recognizes p-tau in PS19 brain sections.

    “Further co-staining experiments with HJ8.5 and VHH-A2-488 in PS19 brain sections at various ages again indicated a consistent brain-wide pattern of human tau expression, but restricted presentation of p-tau recognized by the VHH-A2-488 (Fig. 4).”
3 of 3

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

  • True-positive structures exceed 10%

    Minor

    The stated 36 true-positive structures out of 336 equal 10.7%, not fewer than 10%.

    Reported 10 · recomputed 10.714286

1 of 1

Cites

Flagged first, then by citations

Cited by

Still being checked.

Authors
Ramirez, D. M. O., Whitesell, J. D., Bhagwat, N., Thomas, T. L., Ajay, A. D., Nawaby, A., Delatour, B., Bay, S., LaFaye, P., Harris, J. A., Meeks, J. P., & Diamond, M. I.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • Allen Institute for Brain Science (US)
  • Montreal Neurological Institute and Hospital (CA)
  • Centre National de la Recherche Scientifique (FR)
  • University of Rochester Medicine (US)
Corresponding author
  • Meeks, Julian P.
  • Diamond, Marc I.
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
2025-10
Volume
215
Pages
107072
ISSN
0969-9961 (ISSN-L)
OpenAlex
W4413821186
Cited by
5
References
50
Citations by year
2026: 4 · 2025: 1
FWCI
2.60
Type
journal article
Language
en
Open access
Locations
  • Neurobiology of Disease (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • HAL (Le Centre pour la Communication Scientifique Directe) (submittedVersion, cc-by-nc-nd)
  • PubMed Central (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institute of Neurological Disorders and Stroke
  • National Institute on Aging (RF1AG059689)
  • Rainwater Charitable Foundation
  • National Institutes of Health
  • Allen Institute
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
tauopathy, PS19 mice, structural connectivity, whole-brain imaging, neurodegeneration
MeSH terms
Animals, Brain, Disease Models, Animal, Female, Humans, Male, Mice, Transgenic, Nerve Net, tau Proteins, Disease Progression, Tauopathies, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-24.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-24.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review